Medtech advocacy group AdvaMed is urging the Supreme Court to protect innovation in a False Claims Act (FCA) case.
The highest court in the US will hear an argument combining two cases (Tracy Schutte v. Supervalu, Inc. and Thomas...
Supreme Court Must Protect Medtech Firms By Upholding Objectively Reasonable Standard, AdvaMed Says
Changing the scienter standard basis by rejecting objective reasonability in FCA claims will hurt medtech innovation, according to AdvaMed.
